Abel Hall, LLC

SEC CIK: 0002013339
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overview All 13F holders of ACAD Full Q2 2026 holdings

Shares (Q2 2026): 12,694
Value: $321.2K
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2025

Holdings of ACAD by Abel Hall, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	12,694	$321.2K	0.1%	−1,561−11.0%	Reduced	Holders
Q1 2026	14,255	$317.3K	0.1%	+4,182+41.5%	Added	Holders
Q4 2025	10,073	$269.1K	0.1%	+10,073	New	Holders